Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety, tolerability, and pharmacokinetics/pharmacodynamics of Surovatamig in adult participants with rheumatoid arth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Surovatamig

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis, Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING